UNSPSC 41141620: Lactate dehydrogenase l

In this classification, this entry connotes a Lactate dehydrogenase l enzyme that is used in clinical chemistry testing.

UNSPSC 41141620 Lactate dehydrogenase l (Commodity) is a laboratory diagnostic reagent code that state and local governments use to classify enzyme and bioanalytical assay materials, though recent state and local opportunities show the code applied primarily to genomics sequencing reagents, solid phase extraction disks, culture media, chromatography columns, and certified chemical standards used in public health and clinical diagnostics. The issuing bodies pursuing opportunities under this code span state health departments (Texas Health and Human Services Commission, Mississippi State Department of Health), state agencies (California), municipal procurement (City of Philadelphia), and academic health systems (University of Texas Health Science Center at San Antonio), with Texas HHSC appearing as a repeat buyer across multiple wastewater surveillance, drinking-water testing, and microorganism detection solicitations.

Texas HHSC and the Department of State Health Services account for the largest share of recent activity, issuing multiple IFBs for consumable respiratory pathogen detection kits, culture media for foodborne pathogen testing, Atlantic ReadyDisk HC-C18 solid phase extraction disks, and gas chromatography columns and chemical standards for drinking-water compliance testing. Representative recent opportunities include an IFB (HHS0017272, due May 19, 2026) from Texas HHSC for respiratory pathogen detection kit sets supporting wastewater surveillance with a historical value range of $35,050 to $90,000; an IFB (HHS0017132, due June 2, 2026) from Texas DSHS for culture media for E. coli, Listeria, and Enterobacter detection with a historical value of $187,340 for FY2026; Mississippi State Department of Health sole source procurements for Illumina and Clear Labs whole genome sequencing reagent bundles totaling $393,667.98 and $226,072.00 respectively; and a University of Texas Health Science Center RFP (745-26-P19, due June 4, 2026) for a comprehensive biotech research and clinical diagnostics catalog covering antibodies, chromatography systems, genomics reagents, and immunoassay kits. Recent activity concentrates in Texas and Mississippi, with secondary procurement in California and Philadelphia.